Alap: FTBDF
Franklin Templeton - Franklin Biotechnology Discovery Fund A(acc)USD - 4912 | |
LU0109394709 | |
03.04.2000 | |
Equity | |
Részvény Sectors - Health Care | |
Franklin Templeton Investment Funds | |
Franklin Advisers, Inc. | |
Evan McCulloch | |
USD | |
1 000 | |
5.75% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | -3.98% | 12.55% | 29.84% | 29.77% | 32.84% | 0.18% | 6.80% | 4.97% | 5.46% | N/A | |
Priemerná výkonnosť (36 meraní) | 0.04% | -2.88% | 1.58% | 3.67% | 3.01% | ||||||
Volatilita od priemernej výkonnosti | 9.94% | 29.89% | 9.41% | 6.99% | 5.44% |
Long | Short | Net | |
---|---|---|---|
Részvény | 96.90% | 96.90% | |
Kötvény | |||
Other | 0.61% | 0.61% | |
Pénz piac | 2.49% | 2.49% |
Aktíva | 14 251 mil. |
Počet akcíí | 85 |
Počet dlhopisov | 1 |
Priebež. popl. | 1.81 |
z toho Mng. popl. | 1.50 |
Výk. prémia | |
Trans. popl. | 0.04 |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 2.75% |
Large | 22.36% |
Medium | 19.43% |
Small | 15.58% |
Micro | 32.33% |
P/E | 16.93% |
P/BV | 4.41% |
Basic Materials | 1.29% |
Healthcare | 91.22% |
Corporate | 0.53 |
Derivatives | 2.49 |
Výnos do splatnosti p.a. | 5.20 |
Modifikovaná durácia | 0.00 |
AAA | 0.00 |
AA | 0.00 |
A | 0.00 |
BBB | 0.00 |
BB | 0.00 |
B | 0.00 |
Below B | 0.00 |
Not Rated | 100.00 |
United States | 84.51% |
Canada | 1.03% |
Latin America | |
United Kingdom | 3.61% |
Eurozone | 3.77% |
Europe - ex Euro | 3.99% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 96.90% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Amgen Inc | Healthcare | 6.58% | Regeneron Pharmaceuticals Inc | Healthcare | 6.24% |
Vertex Pharmaceuticals Inc | Healthcare | 5.2% | Ascendis Pharma A/S ADR | Healthcare | 3.99% |
Gilead Sciences Inc | Healthcare | 2.92% | Intra-Cellular Therapies Inc | Healthcare | 2.81% |
Biogen Inc | Healthcare | 2.8% | AstraZeneca PLC ADR | Healthcare | 2.75% |
Jazz Pharmaceuticals PLC | Healthcare | 2.55% | Merus NV | Healthcare | 2.35% |